Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b studyJames J. Harding, Sebastián Mondaca, Hui‐Chuan Sun et al.|The Lancet Oncology|2023Cited by 243
Colony‑stimulating factor CSF2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑STAT3/MYC pathwayHui Li, Ying Cheng|Oncology Reports|2022Cited by 19
c-Myc Targets HDAC3 to Suppress NKG2DL Expression and Innate Immune Response in N-Type SCLC through Histone DeacetylationPeiyan Zhao, Ying Cheng|Cancers|2022Cited by 17
C-Myc-induced hypersialylation of small cell lung cancer facilitates pro-tumoral phenotypes of macrophagesYing Cheng|iScience|2023Cited by 13